Use of the Johnson and Johnson coronavirus vaccine can resume in European countries.
E.U. regulators addressed the possible links to rare blood clot incidents, but said the benefits of the vaccine outweigh the risks.
The European Medicines Agency said a warning about using the vaccine with low blood platelets should be added.
More than seven-million Americans received the vaccine before it was paused, and there were only eight reports of clotting.
Each member of the E.U. will have to decide if they will use the J-and-J vaccine.
Photo: Getty Images